Loading...
•
Jun 30, 2024
Glaukos Q2 2024 Earnings Report
Glaukos' second quarter results reflected successful global execution and growing momentum.
Key Takeaways
Glaukos Corporation reported record net sales of $95.7 million in Q2 2024, a 19% increase year-over-year. The company raised its 2024 net sales guidance to $370 million to $376 million.
Record net sales of $95.7 million in Q2 2024 increased 19% year-over-year on a reported basis and 20% year-over-year on a constant currency basis.
Glaucoma record net sales of $75.9 million in Q2 2024 increased 23% year-over-year.
Corneal Health net sales of $19.8 million in Q2 2024 increased 7% year-over-year.
Gross margin of approximately 76% and non-GAAP gross margin of approximately 82% in Q2 2024.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
The company expects 2024 net sales to be in the range of $370 million to $376 million based on the latest foreign currency exchange rates.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...